Navigation Links
Educating the Marketplace Through Collaborations with Patient Advocacy Groups
Date:5/18/2010

CHAPEL HILL, N.C., May 18 /PRNewswire/ -- Patient and professional advocacy groups are an integral part of educating the marketplace on new medicines. Effectively collaborating with advocacy groups is fundamental for educating the public on treatment options and is especially critical for socially sensitive conditions/therapies. "Collaborating with Patient Advocacy Groups to Educate the Marketplace" is a 125-page report from Best Practices, LLC that identifies successful tactics and strategies for working with patient advocacy groups and managing relationships.

Download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies: http://www3.best-in-class.com/rr999.htm.

In addition to providing a road map for effective collaborations with advocacy groups, this Best Practices, LLC research project also examines ideal structures and skill sets for pharma groups that deal with advocacy groups. Fifty-eight advocacy leaders from 43 companies such as Abbott, Wyeth, Genentech, Novartis, Bayer, Amgen, Astellas, Takeda and J&J shared their practices and insights into advocacy group collaborations. More than a dozen organizations participated in deep-dive interviews to provide actionable insights into working with the advocacy world.

Key topics of this report include:

  • Understanding the Advocacy Landscape
  • Managing Advocacy Relationships
  • Managing Relationships with Hostile Groups
  • Structuring High Performance Biopharma Advocacy Groups
  • Using New Technologies
  • Current Trends and Future Directions

Executives, directors and managers at device, pharmaceutical and biotech organizations who work in patient advocacy functions can use this research to compare their group's approaches and tactics for advocacy group interactions against those of leading organizations.

To learn more about Best Practices' other timely research visit: http://www3.best-in-class.com or contact Jeff Zimmer at 919-767-9180 or jzimmer@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 46 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases
2. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
3. International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
4. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
5. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
8. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
9. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
10. TechMandA.com Marketplace Streamlines M&A Process for Technology Businesses
11. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):